Deutsche Bank downgrades Novartis stock rating to sell on valuation

Markets Investing.com By Investing.com 02 Nov 2026 07:40 1 min read
Deutsche Bank downgrades Novartis stock rating to sell on valuation

Covered in this story

What has happened since

  • Novartis is up 1.9% since this was published, 11 days ago.
  • Deutsche Bank is up 8.5% since this was published, 11 days ago.

Price move measured from the close nearest publication to the latest quote.

Tracked from this story

Deutsche Bank’s CHF115 target on $NOVN.SW is on the record and being tracked to Nov 2027 (12-month default), scored on the close that day.

Deutsche Bank’s track record →

Call it yourself

No member calls on $NOVN.SW yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Novartis →
Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.